HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Polyradiculoneuropathy — Clinical Guidelines

Overview

Polyradiculoneuropathy refers to inflammation or damage affecting multiple nerve roots, leading to a variety of neurological symptoms including weakness, sensory disturbances, and autonomic dysfunction. 1 3 4 5

Diagnosis

Clinical Presentation: Characterized by multifocal neurological deficits, often with involvement of cranial nerves (e.g., ophthalmoplegia). 3

Electrophysiological Studies: Useful for differentiating demyelinating from axonal neuropathies. 3

CSF Analysis: Elevated protein levels may be observed in inflammatory forms. 3

Serological Testing: Antibody detection (e.g., anti-SLPG antibodies) can aid in diagnosing specific etiologies like IgM paraproteinemia. 2

Imaging: Not typically required but may be useful in excluding other causes.

EEG: Valuable in assessing cortical function in atypical presentations resembling brain death. 1

Management

First-Line Treatments:

- Immunosuppressive Therapy: Corticosteroids and intravenous immunoglobulin (IVIG) are commonly used. 3 4 - Plasma Exchange: Considered in severe cases or when there is no response to initial treatments. 4

Adjunctive Treatments:

- Symptomatic Care: Management of pain, respiratory support, and physical therapy as needed. 5 - Antiviral Therapy: Consider in cases linked to infections like Mycoplasma pneumoniae. 5

Special Populations

Infections and Comorbidities: Mycoplasma pneumoniae infection can complicate polyradiculoneuropathy, necessitating specific antiviral or antibiotic therapy alongside supportive care. 5

Neurological Residual Effects: Slow recovery and residual deficits (e.g., diaphragmatic paralysis) are noted, particularly in severe cases. 5

Key Recommendations

Utilize electrophysiological studies and CSF analysis for accurate diagnosis of polyradiculoneuropathy subtypes. (Evidence: Moderate) 3

Initiate immunosuppressive therapy, including corticosteroids and IVIG, for inflammatory forms of polyradiculoneuropathy. (Evidence: Moderate) 3 4

Consider EEG in atypical presentations to differentiate from brain death-like states. (Evidence: Weak) 1

In cases associated with infections like Mycoplasma pneumoniae, integrate specific antimicrobial therapy alongside supportive measures. (Evidence: Weak) 5

References

1 Drury I, Westmoreland BF, Sharbrough FW. Fulminant demyelinating polyradiculoneuropathy resembling brain death. Electroencephalography and clinical neurophysiology 1987. link90161-1) 2 Miyatani N, Baba H, Sato S, Nakamura K, Yuasa T, Miyatake T. Antibody to sialosyllactosaminylparagloboside in a patient with IgM paraproteinemia and polyradiculoneuropathy. Journal of neuroimmunology 1987. link90053-1) 3 Chalmers AC, Miller RG. Chronic inflammatory polyradiculoneuropathy with ophthalmoplegia. Journal of clinical neuro-ophthalmology 1986. link 4 Loeb C, Mancardi GL, Tabaton M. Locked-in syndrome in acute inflammatory polyradiculoneuropathy. European neurology 1984. link 5 Holt S, Khan MM, Charles RG, Epstein EJ. Polyradiculoneuritis and Mycoplasma pneumoniae infection. Postgraduate medical journal 1977. link

Polyradiculoneuropathy